The use of electronic cigarettes

The Australian TGA (Therapeutic Goods Administration) is alerting consumers to the potential risks of purchasing electronic cigarette liquid. We purchased ten nicotine‐free” e‐liquids of a variety of brands and flavours, online and over the counter from Australian suppliers. None disclosed ingredient information beyond vague reporting of the excipient mix and the absence of nicotine. E‐liquids were analysed quantitatively by gas chromatography-mass spectrometry (GC‐MS) in a commercial laboratory ( Supporting Information ).

The use of electronic cigarettes (e-cigarettes), also known as personal vaporisers (PVs), has increased rapidly in Australia despite legal barriers to the sale, possession and use of nicotine for non-therapeutic purposes. Australia is one of many countries in the process of developing regulations for these devices yet knowledge of consumers' views on e-cigarette club regulation is lacking.

The existence of the medical prescription would mean that, the nicotine is supplied in compliance with Schedule 4 of the Poisons Standard (‘Prescription Only') and is therefore no longer prohibited as a Schedule 7- Dangerous Poison under state and territory laws and can be lawfully used. However, the requirement for a medical prescription may pose practical barriers for people in Australia wishing to order nicotine electronic cigarettes online in the event that medical practitioners are unwilling or unable (for legal reasons) to provide a prescription for a product that has not been approved by the TGA.

The American Heart Association requests that this document be cited as follows: Bhatnagar A, Whitsel LP, Ribisl KM, Bullen C, Chaloupka F, Piano MR, Robertson RM, McAuley T, Goff D, Benowitz N; on behalf of the American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Electronic cigarettes: a policy statement from the American Heart Association. Circulation. 2014;130:1418-1436.

Prior e-cigarette users had 4.09 (95% CI, 2.97-5.63) times the odds of ever cigarette use compared with youths with no prior tobacco use ( Table 2 ), while prior other product users had 3.84 (95% CI, 2.63-5.63) times the odds of ever cigarette use. Additionally, the odds of current cigarette use at wave 3 were higher among prior e-cigarette users (OR, 2.75; 95% CI, 1.60-4.73) and prior other product users (OR, 3.43; 95% CI, 1.88-6.26) compared with youths with no prior tobacco use. Sensitivity analyses restricted to youths without missing covariate information yielded similar findings (eTable 2 in the Supplement ).

With new research and opinions on e-cigarettes and other vaping devices coming out all the time, it can be difficult to separate accurate information from biased interpretations of the data. There is a lot of money at stake for e-cigarette manufacturers and distributors and most major cigarette companies now own large shares of the industry. At the same time, many tobacco control and public health professionals may be motivated to advocate for a product that is less risky than smoked cigarettes—the leading, preventable cause of sickness and death in the U.S.

Our award-winning miniature vape pen kits aka miniature vapor cigarettes received incredible reception from reviewers, vapers, and vaping gurus, as soon as we launched them. In addition to winning the Indo Awards for being the best help for ex-smokers to transition to vaping consecutively in 2015 and 2016, the miniature e-cigs have won thousands of hearts also. This feat was achieved by our attitude of never being satisfied with what we've achieved. When we designed our vape pen kits, we wanted to deliver more vapor than any other kit available on the market, but some designers said it was impossible because of the technology limitations. Guess what, impossible” is just a starting point of our innovation.

Their results can be found in a widely accessible version of the Journal of the American Medical Association called JAMA Open. Based on a sample of 445 high-school students whose average age was 19, the researchers observed that teens who used the Juul tended to say they vaped more frequently than those who used other devices. Juul users also appeared to be less aware of how addictive the devices could be compared with teens who vaped other e-cigs.

The majority of e-cigarettes are currently sold as consumer goods; however marketers may seek a medicines licence for their product from the Medicines and Healthcare Products Regulatory Agency (MHRA). Except for rule 22.12 this section applies to marketing communications for e-cigarettes which are licensed as medicines by the MHRA. For products licensed as medicines, the rules in section 12 (Medicines, medical devices, health-related products and beauty products) apply in addition to any other relevant CAP rules.